M
MedeAnalytics
Enterprise data enrichment and analytics platform enhancing healthcare outcomes with advanced data orchestration and interoperability
About MedeAnalytics
MedeAnalytics operates in the healthcare sector, providing a robust enterprise data enrichment and analytics platform. The company serves healthcare payers, providers, and payviders, focusing on improving value-based care initiatives, population health, and quality metrics. MedeAnalytics leverages advanced data orchestration and interoperability to deliver actionable insights that enhance financial, operational, and clinical outcomes. The business model is based on a Software as a Service (SaaS) approach, generating revenue through subscription fees for its analytics solutions. With over 30 years of experience, MedeAnalytics has established itself as a leader in healthcare analytics, offering solutions that reduce costs and improve patient outcomes. The company’s platform is designed to integrate seamlessly with existing data systems, providing clients with the flexibility and effectiveness needed to make informed decisions.
Source: Dealroom company dataAt a glance
- Founded
- 1993
- Headquarters
- Richardson, United States
Knowledge graph
More headlines
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series B and later2 investors entered at this stage
Bain Capital Ventures- JPJLL Partners
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about MedeAnalytics on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See MedeAnalytics on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.